2 assets in Alcoholic Liver Disease

Therapeutic assets addressing Alcoholic Liver Disease, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Human Faecal Matter Alcoholic Liver Disease	Virginia Commonwealth University	P1/2	CCC (48)
Livitol-70 Alcoholic Liver Disease	Composite Interceptive Med Science	N/A	NR ()